Please try another search
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing inhaled therapies to address serious pulmonary diseases and central nervous system (CNS) disorders using its patented inhaled small particles easily respirable and emitted (iSPERSE) technology. Its inhaled therapeutic products based on its dry powder delivery technology, namely iSPERSE enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. Its iSPERSE’s lead development program, PUR1900 is its inhaled formulation of itraconazole, an anti-fungal drug commercially available as an oral drug, which it is developing to treat and prevent pulmonary fungal infections. Its pipeline also includes PUR3100 for the treatment of acute migraine, and PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Name | Age | Since | Title |
---|---|---|---|
Michael J. Higgins | 59 | 2015 | Independent Chairman |
Teofilo David Raad | 51 | 2017 | President, CEO & Director |
Richard P. Batycky | 54 | 2019 | Independent Director |
Michael E. Wechsler | - | - | Member of Pulmazole Clinical Advisory Board |
Mario Castro | - | - | Member of Pulmazole Clinical Advisory Board |
Christopher H. Cabell | 53 | 2020 | Independent Director |
Todd Bazemore | 52 | 2020 | Independent Director |
Anand Varadan | 55 | 2021 | Independent Director |
Cendrine Godet | - | - | Member of Pulmazole Clinical Advisory Board |
David A. Stevens | - | - | Member of Pulmazole Clinical Advisory Board |
Wisla Wedzicha | - | - | Member of PUR1800 Clinical Advisory Board |
Stephen Silberstein | - | - | Chair of PUR3100 (DHE) Clinical Advisory Board |
Jonathan Corren | - | - | Member of Pulmazole Clinical Advisory Board |
Russell G. Clayton | 61 | - | Member of Pulmazole & PUR1800 Clinical Advisory Board |
Peter Wark | - | - | Member of Pulmazole Clinical Advisory Board |
Richard B. Moss | - | - | Member of Pulmazole Clinical Advisory Board |
David W. Denning | - | - | Member of Pulmazole Clinical Advisory Board |
Ritesh Agarwal | - | - | Member of Pulmazole Clinical Advisory Board |
Russell A. Settipane | - | - | Member of Pulmazole Clinical Advisory Board |
Peter J. Goadsby | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Abraham J. Nagy | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Stewart J. Tepper | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Fernando Martinez | - | 2022 | Member of PUR1800 Clinical Advisory Board |
William J. Calhoun | - | - | Chair of PUR1900 & PUR1800 Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review